Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and management of hair loss in children require a detailed examination and understanding of various hair disorders.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Hair thickness matters more than density for baldness in Japanese men over 25.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The dietary supplement helped increase hair growth in women with hair loss.

The new mild shampoo helped prevent hair loss in the subjects.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Hair in the front part of the scalp is more likely to fall out than hair in the back in acute telogen effluvium.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Many new moms lose hair after childbirth due to hormonal changes, but it usually grows back within a year.

Natural substances might help with hair loss and scalp problems.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Baby's toe injury linked to mom's hair loss; check baby's toes and be careful with fruit gel snacks.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

Phenylephrine may help prevent hair loss from pulling on the hair roots.